The importance of glucose transport activity as the rate-limiting step of 2-deoxyglucose uptake in tumor cells in vitro

被引:79
作者
Waki, A [1 ]
Kato, H [1 ]
Yano, R [1 ]
Sadato, N [1 ]
Yokoyama, A [1 ]
Ishii, Y [1 ]
Yonekura, Y [1 ]
Fujibayashi, Y [1 ]
机构
[1] Fukui Med Univ, Biomed Imaging Res Ctr, Matsuoka, Fukui 91011, Japan
关键词
glucose metabolism; deoxyglucose; tumor cells-cultured; rate-limiting; glucose transporter; hexokinase;
D O I
10.1016/S0969-8051(98)00038-9
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Glucose transporter (GLUT) expression and hexokinase activity are thought to be related to high [F-18]-fluorodeoxyglucose (FDG) uptake in tumor cells, but their relative importance is still unknown. To determine which is the predominant factor in FDG uptake in tumor cells, cultured tumor cell lines and a normal cell line were studied in vitro with respect to 2 deoxyglucose (DG) uptake, hexokinase activity, and the initial uptake rate of 3-O-methylglucose (3-O-MG) transport, which is generally accepted as indicating the amount of GLUT expressed on the plasma membrane. In 16 types of tumor cells and one fibroblast cell line, DG uptake was assessed for 60 min, the initial uptake rate of 3-O-MG transport was measured for 1 min, and total hexokinase activity, including that in the mitochondrial fraction, was determined. Across all 16 tumor cell lines, there was a significant correlation between DG uptake and 3-O-MG transport (P = 0.0012, F test), but not between DG uptake and hexokinase activity. Hexokinase activity of the tumor cells was comparable to that of the human fibroblast cells in the exponential growth phase. Most tumor cells showed higher DG uptake and 3-O-MG transport than the human fibroblast cells. The results suggest that DG uptake of cultured tumor cells is governed by GLUT expression, which may be a distinct characteristic of the neoplastic process. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:593 / 597
页数:5
相关论文
共 35 条
[1]   TRANSFORMATION OF RAT FIBROBLASTS BY FSV RAPIDLY INCREASES GLUCOSE TRANSPORTER GENE-TRANSCRIPTION [J].
BIRNBAUM, MJ ;
HASPEL, HC ;
ROSEN, OM .
SCIENCE, 1987, 235 (4795) :1495-1498
[2]   TUMOR HYPOXIA - THE PICTURE HAS CHANGED IN THE 1990S [J].
BROWN, JM ;
GIACCIA, AJ .
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 1994, 65 (01) :95-102
[3]  
BROWN RS, 1993, CANCER, V72, P2979, DOI 10.1002/1097-0142(19931115)72:10<2979::AID-CNCR2820721020>3.0.CO
[4]  
2-X
[5]  
BROWN RS, 1993, J NUCL MED, V34, P75
[6]  
CLAVO AC, 1995, J NUCL MED, V36, P1625
[7]   PET and [F-18]-FDG in oncology: A clinical update [J].
Conti, PS ;
Lilien, DL ;
Hawley, K ;
Keppler, J ;
Grafton, ST ;
Bading, JR .
NUCLEAR MEDICINE AND BIOLOGY, 1996, 23 (06) :717-735
[8]   GLYCOLYSIS - ONE OF THE KEYS TO CANCER [J].
EIGENBRODT, E ;
GLOSSMANN, H .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1980, 1 (09) :240-245
[9]  
EIGENBRODT E, 1986, REGULATION CARBOHYDR, V2, P141
[10]   ELEVATED LEVELS OF GLUCOSE-TRANSPORT AND TRANSPORTER MESSENGER-RNA ARE INDUCED BY RAS OR SRC ONCOGENES [J].
FLIER, JS ;
MUECKLER, MM ;
USHER, P ;
LODISH, HF .
SCIENCE, 1987, 235 (4795) :1492-1495